Timetable for liver transplant outpatients: 8am every Tuesday & Thursday, for blood samples; transplant specialists admitting time: every Wednesday & Friday afternoon.
Internal view of the new surgical ward
Supplemental liver transplant
Expense decreased-les......
No blood transfusion ......
Zhang TongLin
Tenet of the liver transplant club
Members of the club
Activities arrangement
  Your positionHome>>basic knowledge


Treatment of hepatitis B

Liver transplantation has become the most efficient treatment for end-stage liver disease. Without prevention, the recurrent rate of hepatitis B post-transplantation is as high as 80%~100%. Most of these patients will undergo acute, chronic hepatitis, then develop liver cirrhosis, liver failure. Second liver transplantation is usually the only choice of the patients. With the development of medicine, Lamivudine is wide used in clinic to prevent and treat hepatitis B. The rate of positive HBV-DNA to negative is about 60%~70%, but, YMDD mutation is about 21%, which compromises the effect of this medicine. The combined use of large dose of HBIG and LAM abroad to prevent the recurrence of hepatitis B has relatively good result, but it is very expensive. Considering the current status of our country, we modified the protocol, using little dose of HBIG combining LAM for the prevention of hepatitis B after liver transplantation. The modified protocol is less expensive yet with very good result (see “PREVENTION AND TREATMENT OF HEPATITIS B RECURREACE AFTER LIVER TRANSPLANTATION” in 《Hepatobiliary & Pancreatic Diseases International》2003, 2).

Address: No.49, Road north garden, District Haidian, Beijing, 100083 Tel: 010-62017691 ext 7321 010-62010334 Fax: 010-62010334
EMAIL:wcmwy@163.com Copyright(C)2005Peking University Third Hospital All Rights Reserved